Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Waziri

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase ITrisha R Sippel, Jason White, Kamalika Nag, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastomaAllen Waziri, Brendan Killory, Alfred T Ogden, et al.
Neurosurgery|October 14, 2006
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomasAlfred T Ogden, David Horgan, Allen Waziri, et al.
Neuro-Oncology|June 11, 2013
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastomaJonathon J Parker, Kalen R Dionne, Rada Massarwa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2013
Characterization of distinct immunophenotypes across pediatric brain tumor typesAndrea M Griesinger, Diane K Birks, Andrew M Donson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiformeChanghu Chen, Denise Damek, Laurie E Gaspar, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 11, 2008
Microphysiology of epileptiform activity in human neocortexCatherine A Schevon, Sau K Ng, Joshua Cappell, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase ITrisha R Sippel, Jason White, Kamalika Nag, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastomaAllen Waziri, Brendan Killory, Alfred T Ogden, et al.
Neurosurgery|October 14, 2006
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomasAlfred T Ogden, David Horgan, Allen Waziri, et al.
Neuro-Oncology|June 11, 2013
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastomaJonathon J Parker, Kalen R Dionne, Rada Massarwa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2013
Characterization of distinct immunophenotypes across pediatric brain tumor typesAndrea M Griesinger, Diane K Birks, Andrew M Donson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiformeChanghu Chen, Denise Damek, Laurie E Gaspar, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 11, 2008
Microphysiology of epileptiform activity in human neocortexCatherine A Schevon, Sau K Ng, Joshua Cappell, et al.
Pageof 4